Nuvectis Pharma, Inc. — Director's Dealing 2025

Nov 6, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvectis Pharma, Inc. (NVCT)
CIK: 0001875558
Period of Report: 2025-11-05

Reporting Person: BENTSUR RON (Director, Chairman & CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-11-05	Common Stock	P	5000	$5.72	Acquired	3525924	Direct

Footnotes

F1: Includes 676,759 shares of restricted stock.